13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 47 holding rows worth $418,066,029.
- Accession
- 0001493152-23-028636
- Filer
- CIK 1595855
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 47 entries on the cover page, a total value of $418,066,029 stated on the cover page (in dollars after the unit check, H1), rows summing to $418,066,029 with VALUE read as dollars as filed, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACELYRIN INC | 00445A100 | COM | 4,158,638 | $86,915,534 | dollars as filed | |
| HARROW INC | 415858109 | COM | 3,775,000 | $71,876,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,780,000 | $29,824,800 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 1,580,000 | $16,005,400 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 845,000 | $15,226,900 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 352,650 | $14,169,477 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 540,000 | $12,916,800 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 735,000 | $12,120,150 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 415,000 | $9,752,500 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,209,380 | $9,034,069 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 177,000 | $8,839,380 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 2,285,000 | $7,974,650 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,350,000 | $7,543,500 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 625,000 | $6,787,500 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 720,000 | $6,480,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,692,594 | $6,435,300 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 815,000 | $6,316,250 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 566,700 | $6,205,365 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 570,000 | $5,899,500 | dollars as filed | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 543,500 | $5,625,225 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 597,500 | $5,574,675 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 217,000 | $5,197,150 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 120,000 | $4,893,600 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 570,700 | $4,479,995 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,390,000 | $4,350,700 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 130,000 | $4,240,600 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,701,500 | $4,066,585 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 3,370,000 | $4,044,000 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 221,700 | $4,006,119 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 445,000 | $3,564,450 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 380,000 | $3,503,600 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 1,785,000 | $3,195,150 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 421,000 | $2,963,840 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,074,995 | $2,951,995 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 305,000 | $2,540,650 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 675,000 | $1,890,000 | dollars as filed | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 3,310,000 | $1,820,500 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 307,000 | $1,427,550 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 275,000 | $1,388,750 | dollars as filed | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 4,764,508 | $1,386,472 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 653,000 | $1,057,860 | dollars as filed | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 669,944 | $917,823 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 102,000 | $758,880 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 275,000 | $594,750 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 63,500 | $586,105 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 143,600 | $473,880 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 98,796 | $242,050 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-23-028636 | this filing | 2023-08-14 | acceptance time not in the bulk data set |